Rovi stock: pharmaceutical group trades pre-market at EUR 58.10
Published on 10/19/2026 at 07:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness and dates ahead
- Rovi operates as a pharmaceutical laboratory in the health field.
- The next scheduled company event is the first nine months 2026 financial results on November 5, 2026.
- Rovi stock trades pre-market at EUR 58.10 at 7:50 a.m. CEST at Lang & Schwarz on October 19, 2026.
Rovi operates as a pharmaceutical laboratory in the health field, according to the company’s investor information. Rovi stock trades pre-market at EUR 58.10 at 7:50 a.m. CEST at Lang & Schwarz on October 19, 2026.
Ahead of the Xetra open
Lang & Schwarz showed Rovi in pre-market trading before the Xetra session. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Rovi stock.
The group and its calendar
Rovi operates as a pharmaceutical laboratory in the health field. The company’s investor calendar lists its first nine months 2026 financial results for November 5, 2026, as stated on the Rovi investor-relations website. Market context: Market report IBEX 35.
Disclaimer...
en | ES0157261019 | ROVI | boerse | 70357713 | bgmi
